Induction of transferase bands. Transferase purified from phenobarbital-treated B6 mice was homogeneous by SDS/polyacrylamide-gel electrophoresis and had a subunit M, of 51000. Antibodies against the purified transferase immunocomplexed a 51 kDa and a 54kDa protein (Fig. 1) . Both complexes were recovered by binding to protein ASepharose. After the various treatments described in Fig. 1 , it can be seen that the 51 kDa and 54kDa proteins were induced to the greatest extent in B6 mice by phenobarbital and 3-methylcholanthrene compared with the effects of these compounds in D2 mice. TCDD induced both bands in both strains equally. In each case with these three inducers, the best response was in the 54 kDa band. Benzo[a]pyrene preferentially induced the 54 kDa band, whereas benzanthracene preferentially induced the 51 kDa protein in B6 mice. trans-Stilbene oxide did not affect either protein.
Results and discussion
Induction of transferase bands. Transferase purified from phenobarbital-treated B6 mice was homogeneous by SDS/polyacrylamide-gel electrophoresis and had a subunit M, of 51000. Antibodies against the purified transferase immunocomplexed a 51 kDa and a 54kDa protein (Fig. 1) . Both complexes were recovered by binding to protein ASepharose. After the various treatments described in Fig. 1 , it can be seen that the 51 kDa and 54kDa proteins were induced to the greatest extent in B6 mice by phenobarbital and 3-methylcholanthrene compared with the effects of these compounds in D2 mice. TCDD induced both bands in both strains equally. In each case with these three inducers, the best response was in the 54 kDa band. Benzo [a] pyrene preferentially induced the 54 kDa band, whereas benzanthracene preferentially induced the 51 kDa protein in B6 mice. trans-Stilbene oxide did not affect either protein.
Protease and endoglycosidase digestions. In order to determine whether the two bands contained similar peptides, each band excised from disc gels was digested separately with Staphylococcus aureus V8 protease during electrophoresis on a 12%-polyacrylamide/SDS slab gel. The peptide maps were similar, suggesting that both the 51 kDa and 54 kDa proteins were indeed transferase. Both proteins were resistant to trypsin digestion. Since the two proteins had similar peptide fragments and both proteins were recognized by antibodies raised against the 51 kDa protein, it was considered possible that at least a core of primary structure is similar for the two proteins and that one or both may be further modified by glycosylation and/or proteolytic processing to produce mature proteins with different M , values. Endoglycosidase H treatment of labelled microsoma1 preparations altered the 5 1 kDa but not 54 kDa protein. Endoglycosidase D did not affect either protein.
Translation of transferase mRNA. Immunoprecipitation of protein translated in vitro with anti-transferase immunoglobulin G by using total mRNA from phenobarbital-treated B6 mice again generated two protein bands, of about 50 kDa and 54 kDa. After inclusion of dog pancreatic microsomes during translation, the 5OkDa band increased to 51 kDa, and the 54kDa band was unchanged. The two products translated in vitro had a pattern similar to that in microsomes. These results indeed indicate that the 51 kDa protein in microsomes is post-translationally modified by glycosylation to a mature protein.
The observation that two proteins were generated during the translation in uitro demonstrates that two different mRNA species must code for them. Thus the two proteins exist in microsomes such that one is not a digested product of the other. Furthermore, it is likely that the glycosylated 51 kDa protein is inserted in the luminal side of the endoplasmic reticulum, since that is the only site in the cell known to glycosylate proteins (Boulan et al., 1978) . The 54 kDa transferase, however, appears to be unglycosylated and most probably would be located at a different site in the membrane.
The differences in location of these two transferase enzymes in the endoplasmic-reticulum membrane most probably dictates the accessibility of aglycones to the enzymes' active sites and, ultimately, their participation in glucuronidating activity.
Conjugation with glucuronic acid is a major pathway in the metabolism and elimination of drugs and endogenous compounds such as steroids and bilirubin. This reaction is probably catalysed by a family of closely related enzyme forms of UDP-GT* with different but overlapping substrate specificities. The enzyme has attracted many scientists because of a variety of interesting features, such as the phospholipid-dependence of its catalytic activity, latency of UDP-GT activity in the microsomal membrane and differential inducibility of the multiple enzyme forms by hormones and xenobiotic inducers (Dutton, 1980) . Because of its complex regulation, UDP-GT activity has been * Abbreviations : UDP-GT, UDP-glucuronosyltransferase (EC 2.4. I . 17); IgG, immunoglobulin G . difficult to interpret. However, recent advances in the isolation and purification of several enzyme forms of UDP-GT (for references, see Bock et al., 1983) and the availability of antibodies against the enzyme greatly helped elucidation of some of the ambiguities about enzyme induction.
Differential induction of UDP-glucuronosyltransferase activities
Hormones and xenobiotic inducers have been known as regulatory factors of UDP-GT activity since the report of Inscoe & Axelrod (1 960). This regulatory control seemed to be remarkably similar to that found previously for cytochrome P-450-dependent mono-oxygenases (Conney et al., 1956; Quinn et al., 1958) . Later it was found that the two prototypes of xenobiotic inducers, 3-methylcholanthrene and phenobarbital, differentially increased UDP-GT activities (Bock et al., 1973; Wishart, 1978a) . The model of differential induction of rat liver microsomal UDP-GT activities has been extended to a variety of other inducers Watkins et al., 1982) . It has been VOl. 12 used to classify UDP-GT reactions. At least three groups of UDP-GT activities can be clearly distinguished (Fig. 1) . Conjugation of group-1 substrates (mostly planar phenols) is markedly ( > 2-fold) inducible by 3-methylcholanthrene. Independent regulatory control of group-1 activities is also observed in studies on the perinatal development of rat liver UDP-GT activities (Wishart, 19786; Dutton & Leakey, 1981) . In the latter model group-1 activities appear before birth (late-foetal cluster), whereas all other UDP-GT activities develop after birth (neonatal cluster). Independent regulation as well as co-purification of group-1 activities during enzyme purification (Bock et al., 1979) suggested that group-1 activities may be catalysed by a distinct enzyme form. This enzyme form appears to show some regioselectivity for planar phenolic substrates. Whereas 3-hydroxybenzo[a]pyrene has been classified as a typical group-1 substrate, UDP-GT activity towards 9-hydroxybenzo[a]pyrene was only moderately induced by either 3-methylcholanthrene (1.6-fold) or phenobarbital (1.8-fold). This suggests that 9-hydroxybenzo[a]pyrene is mainly conjugated by enzyme forms different from the 3-methylcholanthrene-inducible UDP-GT.
UDP-GT activities towards group-2 substrates, including bulky non-planar phenols such as morphine and 4-hydroxybiphenyl, are markedly inducible by phenobarbital. Although morphine UDP-GT has been isolated and purified (Bock et al., 1979) , the isolated enzyme did not conjugate 4-hydroxybiphenyl. Hence it is questionable whether all group-2 activities are catalysed by a single enzyme form. UDP-GT activities towards bilirubin and testosterone are only moderately inducible by phenobarbital treatment. Selective inducibility of bilirubin UDPGT activity by clofibrate and pregnenolone 16a-carbonitrile (Watkins et al., 1982) , as well as enzyme purification (Burchell, 1982) , suggest that bilirubin UDPGT may be a separate enzyme form. Furthermore, testosterone UDPGT has also been identified as a separate Induction factor Fig. 1 . Dgferential induction of rat liver microsomal UDPglucuronosyltransferase activities The induction factor is the ratio of liver microsomal UDP-GT activities in induced animals to that in untreated controls. Data are taken from Bock et al. (1979 Bock et al. ( , 1980 and Ullrich & Bock (1983) . entity (Matern et al., 1982) . UDP-GT activities towards group-3 substrates, including oestrone and a number of drugs, are not markedly increased (< 2-fold) by either 3-methylcholanthrene or phenobarbital.
Functional heterogeneity of UDP-GT activities, indicated by their differential inducibility, and the results of enzyme purification suggest at least five different enzyme forms of UDP-GT, with 4-nitrophenol, morphine, bilirubin, testosterone and oestrone as typical substrates (see Bock et al., 1983) . Genetic evidence suggests that the 3-methylcholanthrene-inducible enzyme form of UDP-GT is co-ordinately induced with cytochrome P,-450 (Owens, 1977) . This co-ordinate induction of some metabolic pathways may facilitate detoxication of arylhydrocarbons (Bock et al., , 1984 ).
Purijication of the major 3-methylcholanthrene-inducible enzyme form of UDP-glucuronosyltransferase : properties of rabbit antibodies against this enzyme form
To be able to distinguish changes in the enzyme amount (induction) and modulation of enzyme activity by alterations of its membrane environment, we purified the 3-methylcholanthrene-inducible enzyme form and raised antibodies against it in rabbits (Pfeil . The purified enzyme had a subunit M , of 54000 (determined by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis) and a M, of about 220000 (determined by gel chromatography), suggesting the formation of tetramers. This oligomeric structure may greatly influence the incorporation and properties of the enzyme in the microsomal membrane. Rabbit antibodies against UDP-GT showed single continuous precipitation lines between the purified enzyme and solubilized microsomal proteins. The antibody precipitated and inhibited UDP-GT activities (Fig. 2) , but did not precipitate NADPH+ytochrome c reductase. Qualitatively similar results were obtained with antiserum or when the amount of IgG was varied. Inhibition was greater with the solubilized than with the membrane-bound enzyme. Nevertheless the membrane-bound enzyme activitity was clearly inhibited by antibody, indicating that antigenic sites of the enzyme are exposed at the cytoplasmic site of the microsomal vesicle. The antibody showed some specificity for the 3-rnethylcholanthrene-inducible enzyme form, since group-1 activities were precipitated to greater extents than those of other groups (Pfeil & Bock, 1983) . With these antibodies, an electroimmunochemical assay was developed to quantify the enzyme protein. These studies substantiated that the administration of 3-methylcholanthrene, but not of phenobarbital, led to a selective increase in the amount of the enzyme. In studies with isolated hepatocytes from phenobarbital-and 3-methylcholanthrene-treated rats it could be demonstrated that, apart from cofactor supply, the amount of enzyme is a major factor determining glucuronide formation in the intact cell (Ullrich & Bock, 1983) .
'Permanent induction' of UDP-glucuronosyltransferase in pre-neoplastic liver lesions and its modulation by the tumour promoter phenobarbital
In previous studies it was recognized that some hepatomas showed high UDP-GT activity (Lueders et al., 1970; Bock & White, 1974) . We previously demonstrated that UDP-GT activities towards group-1 substrates were selectively increased in hyperplastic liver nodules obtained by continuous feeding of 2-acetyl-aminofluorene in the diet (Eriksson et al., 1981 ; . Epoxide hydrolase and glutathione S-transferase were also increased in these hyperplastic liver nodules. In contrast, cytochrome P-450-dependent mono-oxygenases were found to be decreased. This altered pattern of drug-metabolizing enzymes is 
Fig. 2. Immunoprecipitation and inhibition of UDP-glucuronosyltransferase activity towards I-naphthol by rabbit IgG against the rat liuer enzyme
Rat liver microsomal fractions from 3-methylcholanthrenetreated rats in the native and activated state of UDP-GT were prepared as described (Bock & White, 1974) , except that Brij 58 (0.5mg/mg of protein) was used to activate the enzyme. Microsomal fractions were solubilized by both sonication and addition of Brij 58 (I%, w/v), and centrifuged at lOOOOOg for 1 h. Rabbit IgG against UDP-GT or non-immune IgG was incubated with the solubilized and membrane-bound enzyme (one-tenth of the amount of IgG protein) for 2h at 4°C. UDP-GT activity towards 1-naphthol was determined either directly (inhibition) or in the supernatant after centrifugation at 1OOOOg. Open and hatched bars represent GT activity of incubations with nonimmune IgG (controls) and immune IgG respectively. The means S.D. for three experiments are shown.
consistent with increased resistance of pre-neoplastic hepatocytes to the cytotoxic actions of chemical carcinogens (Tsuda et al., 1980) . Increased UDP-GT could also be demonstrated in early pre-neoplastic liver foci both immunohistochemically and enzymically in microdissected tissue from focal and extrafocal liver (Fischer et al., 1983) . Using these techniques we were able to study separately the effects of initiators and tumour promoters on the regulation of UDP-GT activity (Fig. 3) . N-Nitrosomorpholine (75 mg/kg, administered once intraperitoneally 24 h after partial hepatectomy) was used as the initiator, and phenobarbital (0.1%, administered 1 week later in drinking water) as the tumour promoter. In the group of animals which received only N-nitrosomorpholine, UDP-GT activity was still increased 5-fold in focal tissue at 330 days after initiation. This permanent alteration of UDP-GT expression (operationally termed 'permanent induction') has to be distinguished from regular induction, which is reversible within 1-2 weeks. However, the permanently increased enzyme activity could still be further induced by the tumour promoter phenobarbital. When phenobarbital was withdrawn 14 days before the animals were killed, UDP-GT activity was similar to that found in animals that had only received the initiator. Hence the tumour promoter was able to increase gene expression further. Administration of both phenobarbital and 3-methylcholanthrene did not further
VOl. 12 increase UDP-GT activity in focal tissue, suggesting that enzyme was maximally induced.
Conclusions
Differential induction of multiple UDP-glucuronosyltransferases will continue to be of great help to characterize further various enzyme forms and to elucidate their functions. Multiple enzyme forms may facilitate metabolic control of various endogenous substrates and detoxication of dietary constituents such as aryl hydrocarbons. Permanently increased UDP-GT activity may be a useful marker for the altered phenotype observed in pre-neoplastic liver lesions. It may provide clues to the altered gene expression occurring at different stages of chemical carcinogenesis and to its modulation by tumour promoters.
We are grateful to the Deutsche Forschungsgemeinschaft and the Stiftung Volkswagenwerk for financial support. Table 1 presents the patterns of induction by the so-called classical inducers phenobarbital and 3-methylcholanthrene and by the newly characterized inducers trans-stilbene oxide and 2-acetylaminofluorene. A number of characteristics of these patterns should be noted. In the first place transstilbene oxide has been found to induce the same isoenzyme of cytochrome P-450 as is induced by phenobarbital, whereas 2-acetylaminofluorene induces a form of this cytochrome which is clearly distinct from those induced both by phenobarbital and 3-methylcholanthrene. This seems to be a rather general phenomenon: many xenobiotics induce the same isozymes of cytochrome P-450 as do phenobarbital or 3-methylcholanthrene, whereas many other xenobiotics induce distinct isoenzymes. In addition, many xenobiotics induce more than one isoenzyme of cytochrome P-450. An important task for the immediate future will be to compare the distinct isoenzymes induced by different xenobiotics to determine which of them are the same and thereby classify them into different groups.
Table 1 also shows that 3-methylcholanthrene induces the phase-I P-450 system to a much greater extent than the phase-I1 enzymes microsomal epoxide hydrolase and cytosolic glutathione transferases; phenobarbital induces both phase-I and -11 reactions to approximately the same extent; whereas both trans-stilbene oxide and 2-acetylaminofluorene induce microsomal epoxide hydrolase and cytosolic glutathione transferases to a much greater extent than they induce the total amount of cytochrome P-450. Of course, many more detailed patterns of induction will be discernible when the induction of different isoenzymes and of other enzymes such as UDP-glucuronosyltransferase, sulphotransferase and DT-diaphorase (NADCP)H : oxidoreductase) are also taken into account. trans-Stilbene oxide, for instance, has been found to induce all the major isoenzymes of cytosolic glutathione transferase in rat liver (Guthenberg et al., 1980) as well as to be a powerful inducer of cytosolic DT-diaphorase (Lind et al., 1980 ) (see also below).
It is, of course, of great importance to characterize the pattern of induction of drug-metabolizing enzymes by different xenobiotics in such detail. Since reactive intermediates produced by the cytochrome P-450 system are often the direct cause of the toxic and genotoxic effects of different xenobiotics, the differential induction of phase-I and -11 activities may have a profound influence on the toxicity and genotoxicity of the inducer itself and of other xenobiotics as well (synergistic effects). In addition, the metabolism of endogenous compounds may be strongly affected by such differential induction (Meijer & DePierre, 1983) .
There are also distinct differences in the induction of drug-metabolizing enzymes in extrahepatic tissues by phenobarbital, 3-methylcholanthrene and trans-stilbene oxide (DePierre et al., 1984) . For instance, 3-methylcholanthrene induces cytosolic glutathione transferase activity significantly only in the liver, and phenobarbital induces this activity in the intestine as well, whereas trans-stilbene oxide induces cytosolic glutathione transferase activity in the liver, kidney and adrenal gland. Such differences may again have a great influence on the relative susceptibility of different organs to toxic and genotoxic effects.
In view of these and other considerations, it does not seem fruitful to continue to consider phenobarbital and 3-methylcholanthrene as representative inducers with which other inducers should be compared.
It is also apparent from Table 1 that neither phenobarbital, 3-methylcholanthrene, trans-stilbene oxide nor 2-
